AZD 8309
Alternative Names: AZD8309Latest Information Update: 17 Sep 2019
At a glance
- Originator AstraZeneca
- Class Amines; Anti-inflammatories; Antirheumatics; Fluorobenzenes; Pyrimidines; Small molecules; Sulfides; Thiazoles
- Mechanism of Action Interleukin 8B receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Chronic obstructive pulmonary disease; Pancreatitis; Rheumatoid arthritis
Most Recent Events
- 17 Sep 2019 Chemical structure information added
- 01 Feb 2007 Discontinued - Phase-I for Chronic obstructive pulmonary disease in United Kingdom (unspecified route)
- 01 Feb 2007 Discontinued - Phase-I for Rheumatoid arthritis in United Kingdom (unspecified route)